1 |
Parlakpinar H, Gunata M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacol Immunotoxicol 2021;43:651-65. [PMID: 34415233 DOI: 10.1080/08923973.2021.1966033] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment. Ther Apher Dial 2019;23:4-21. [PMID: 30294946 DOI: 10.1111/1744-9987.12763] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
|
3 |
Han SR, Cho MH, Moon JS, Ha IS, Cheong HI, Kang HG. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation. Kidney Blood Press Res 2019;44:1300-5. [PMID: 31522186 DOI: 10.1159/000502289] [Reference Citation Analysis]
|
4 |
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, Werthmann PG, Moher D, Rison RA, Shamseer L, Koch CA, Sun GH, Hanaway P, Sudak NL, Kaszkin-Bettag M, Carpenter JE, Gagnier JJ. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218-235. [PMID: 28529185 DOI: 10.1016/j.jclinepi.2017.04.026] [Cited by in Crossref: 232] [Cited by in F6Publishing: 208] [Article Influence: 46.4] [Reference Citation Analysis]
|
5 |
Bhatti S, Alghamdi M. Atypical Hemolytic Uremic Syndrome After Liver Transplant Treated With Eculizumab. Cureus 2020;12:e9230. [PMID: 32821578 DOI: 10.7759/cureus.9230] [Reference Citation Analysis]
|